Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Roundhill GLP-1 & Weight Loss ETF (NQ:OZEM)

35.84 -0.09 (-0.24%)

Streaming Delayed Price Updated: 10:19 AM EST, Feb 2, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	6,560
Open	35.51
Bid (Size)	35.78 (200)
Ask (Size)	35.87 (500)
Prev. Close	35.92
Today's Range	35.29 - 35.84
52wk Range	20.01 - 37.15
Shares Outstanding	N/A
Dividend Yield	1.14%

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Ozempic, Mounjaro, Wegovy, or Zepbound? This ETF Holds Them All ↗

January 19, 2026

Via MarketBeat

Eli Lilly Extends Lead In $150B Obesity Drug Race As Novo, Pfizer Clash — Here's How ETFs Stand To Gain ↗

October 30, 2025

As Eli Lilly, Novo Nordisk, and Pfizer battle for dominance in the obesity-drug market, these ETFs are offering exposure to the GLP-1 gold rush.

Via Benzinga

Performance

YTD	+4.4%	+4.4%
1 Month	+4.4%	+4.4%
3 Month	+23.5%	+23.5%
6 Month	+46.1%	+46.1%
1 Year	+47.7%	+47.7%

More News

Are You Making These 3 ETF Mistakes That Cost You 50% in Gains? ↗

October 13, 2025

Via The Motley Fool

Why Wegovy Maker Novo Nordisk’s Stock Is Sliding 3% Premarket Today ↗

September 29, 2025

Via Stocktwits

Eli Lilly's Blockbuster Obesity Drugs Miss Sales Estimates Again, But Investors Cheer Q4 Earnings Beat ↗

February 06, 2025

Via Stocktwits

Eli Lilly Gets Wall Street Backing After Tuesday’s Turmoil, Stock Rises Premarket As Retail Stays Bullish ↗

January 15, 2025

Via Stocktwits

Eli Lilly Stock Faces Worst Day In Nearly 4 Years On Q4 Weight-Loss Drug Sales Miss, But Retail Bullish On 2025 Projections ↗

January 14, 2025

Via Stocktwits

Eli Lilly Stock Soars 34.42% YTD: A $1000 Investment Outpaces Returns From These ETFs Holding Mounjaro-Maker Shares ↗

December 13, 2024

Via Benzinga

EXCLUSIVE: Weight-Loss Duopoly Breaks As Eli Lilly, Novo Plummet; 'Market Won't Be Dominated By Just 2 Players' ↗

July 18, 2024

Via Benzinga

ETFs Bet High On Weight Loss Drugs, But Industry Observers Question Long-Term Potential ↗

June 07, 2024

Via Benzinga

New Weight Loss ETF Is Essentially A Play On Eli Lilly, Novo Nordisk ↗

May 30, 2024

Via Benzinga

Tesla (TSLA) Stock Drops as Glass Lewis Urges Against Elon Musk’s Pay Package ↗

May 28, 2024

Via InvestorPlace

Campbell Soup Layoffs 2024: What to Know About New Campbell Job Cuts ↗

May 28, 2024

Via InvestorPlace

OZEM ETF: 7 Things to Know About the New Roundhill GLP-1 & Weight Loss ETF ↗

May 28, 2024

Via InvestorPlace

South Park Took On Crypto, AI Previously: Animated Comedy Targets Weight-Loss Drug Ozempic Next ↗

May 23, 2024

Via Benzinga

EXCLUSIVE: Roundhill Investments Launches Weight Loss ETF For Exposure To Blockbuster Drugs Like Ozempic ↗

May 21, 2024

Via Benzinga

Frequently Asked Questions

Is Roundhill GLP-1 & Weight Loss ETF publicly traded?

Yes, Roundhill GLP-1 & Weight Loss ETF is publicly traded.

What exchange does Roundhill GLP-1 & Weight Loss ETF trade on?

Roundhill GLP-1 & Weight Loss ETF trades on the Nasdaq Stock Market

What is the ticker symbol for Roundhill GLP-1 & Weight Loss ETF?

The ticker symbol for Roundhill GLP-1 & Weight Loss ETF is OZEM on the Nasdaq Stock Market

What is the current price of Roundhill GLP-1 & Weight Loss ETF?

The current price of Roundhill GLP-1 & Weight Loss ETF is 35.84

When was Roundhill GLP-1 & Weight Loss ETF last traded?

The last trade of Roundhill GLP-1 & Weight Loss ETF was at 02/02/26 10:19 AM ET

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.